Last Updated: August 6, 2026

Drug Price Trends for STIOLTO


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for STIOLTO

Average Pharmacy Cost for STIOLTO

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
STIOLTO RESPIMAT INHALER (60) 00597-0155-61 115.82046 GM 2026-07-22
STIOLTO RESPIMAT INHALER (60) 00597-0155-61 115.81415 GM 2026-06-17
STIOLTO RESPIMAT INHALER (60) 00597-0155-61 115.84972 GM 2026-05-20
STIOLTO RESPIMAT INHALER (60) 00597-0155-61 115.83495 GM 2026-04-22
STIOLTO RESPIMAT INHALER (60) 00597-0155-61 115.84603 GM 2026-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Subscribe to access the full database, or Start Trial

Best Wholesale Price for STIOLTO

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
STIOLTO RESPIMAT Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0155-70 0.667GM 50.25 75.33733 GM 2022-09-15 - 2027-09-14 FSS
STIOLTO RESPIMAT 2.5MCG/2.5MCG INHL Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0155-61 4 296.54 74.13500 EACH 2022-09-15 - 2027-09-14 FSS
STIOLTO RESPIMAT Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0155-70 0.667GM 42.11 63.13343 GM 2023-01-01 - 2027-09-14 Big4
STIOLTO RESPIMAT 2.5MCG/2.5MCG INHL Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0155-61 4 296.54 74.13500 EACH 2023-01-01 - 2027-09-14 Big4
STIOLTO RESPIMAT Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0155-70 0.667GM 50.25 75.33733 GM 2023-01-01 - 2027-09-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links